<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 2456         </title>
<shortdesc>DHFS-SERIOUS MENTAL ILLNESS</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Lindsey LaPointe-Dagmara Avelar-Maurice A. West, II, Nicholas K. Smith, Aarón M. Ortíz, Camille Y. Lilly, Michelle Mussman, Yolonda Morris and William E Hauter</sponsors>
</sponsor>
<lastaction>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>305 ILCS 5/5-5.12f new</reference><aliasreference></aliasreference><SynopsisText>     Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that for the purpose of removing barriers to the timely treatment of serious mental illnesses, prior authorization mandates and utilization management controls shall not be imposed under the fee-for-service and managed care medical assistance programs on any FDA-approved prescription drug that is recognized by a generally accepted standard medical reference as effective in the treatment of conditions specified in the most recent Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association. Provides that the following shall be permitted for prescription drugs covered under the amendatory Act: (i) clinically appropriate drug utilization review (DUR) edits, including, but not limited to, drug-to-drug, drug-age, and drug-dose; (ii) generic drug substitution if a generic drug is available for the prescribed medication in the same dosage and formulation; and (iii) any utilization management control that is necessary for the Department of Healthcare and Family Services to comply with any current consent decrees or federal waivers. Defines "serious mental illness".</SynopsisText></synopsis>
<actions>
<statusdate>2/15/2023</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Lindsey LaPointe</action>
<statusdate>2/15/2023</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>2/15/2023</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/27/2023</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Maurice A. West, II</action>
<statusdate>2/28/2023</statusdate><chamber>House</chamber><action>Assigned to Appropriations-Health &amp; Human Services Committee</action>
<statusdate>3/1/2023</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Dagmara Avelar</action>
<statusdate>3/1/2023</statusdate><chamber>House</chamber><action>Chief Co-Sponsor Changed to Rep. Dagmara Avelar</action>
<statusdate>3/9/2023</statusdate><chamber>House</chamber><action>To Medicaid &amp; Managed Care Subcommittee</action>
<statusdate>3/10/2023</statusdate><chamber>House</chamber><action>Committee/3rd Reading Deadline Extended-Rule May 19, 2023</action>
<statusdate>3/13/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Nicholas K. Smith</action>
<statusdate>3/13/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Aarón M. Ortíz</action>
<statusdate>3/13/2023</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Camille Y. Lilly</action>
<statusdate>5/19/2023</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>2/26/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Michelle Mussman</action>
<statusdate>3/7/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Yolonda Morris</action>
<statusdate>3/11/2024</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. William E Hauter</action>
<statusdate>1/7/2025</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

